Search Results 401-410 of 16990 for pharmacogenetics
Inclusion Criteria: 18 years of age or older; Either ST segment elevation myocardial infarction or Non ST segment elevation myocardial infarction consistent ...
Read news highlighting gene studies in Parkinson's disease from Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter ...
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
To investigate the utility of RNA analysis in diagnosis of patients with cancer predisposition syndromes and collection of patient samples with pathogenic or ...
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...
Intro: It could be your mom, sister, aunt or best friend. One out of eight women will get breast cancer in her lifetime. A small subset of the women who get ...
1. It's already influenced drug labels and uses for some medicines. The U.S. Food and Drug Administration has changed medication labeling, doses and uses ...
The purpose of this research is to study immune cells called T cells and monocytes (types of blood cells that fight infection and can also cause autoimmune ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.